U.S. Supreme Court Asked To Find That Off-Label Use Of Infuse Is Not Preempted

Mealey's (September 24, 2015, 12:07 PM EDT) -- WASHINGTON, D.C. — An Infuse bone graft plaintiff on Sept. 11 asked the U.S. Supreme Court to decide if its medical device preemption precedents preempt claims involving the off-label use of devices (Patricia Caplinger v. Medtronic, Inc., et al., No. 15-321, U.S. Sup.)....

Attached Documents

Related Sections